Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker HNGE
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Deer X & Co. Ltd. | 1.91M | 3.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Deer X & Co. L.P. | 1.91M | 3.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Bessemer Venture Partners X Institutional L.P. | 924,196 | 1.5% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Bessemer Venture Partners X L.P. | 984,511 | 1.6% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Holdings Group, LLC | 6.44M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Associates X, Ltd. | 6.44M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Associates X, L.P. | 6.44M | 9.4% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners X (Co-Investors), LP | 76,545 | 0.1% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners (Delaware) X, LP | 510,292 | 0.7% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners (Cayman) X, LP | 2.64M | 3.8% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners X, LP | 3.22M | 4.7% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Qian Zhuang | 2.46M | 4.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital Ivy Partners, LLC | 552,680 | 0.9% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital IVY, LLC | 552,680 | 0.9% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital HH, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital I Partners, LLC | 1.91M | 3.1% | SCHEDULE 13G/A ↗ |
| Aug 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital I, L.P. | 1.91M | 3.1% | SCHEDULE 13G/A ↗ |
| Jul 28, 2026 | SCHEDULE 13G | HNGE Hinge Health, Inc. | BlackRock, Inc. | 2.99M | 5.5% | SCHEDULE 13G ↗ |
| Jun 8, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico IV (Guernsey), L.P. | 2.30M | 2.9% | SCHEDULE 13G/A ↗ |
| Jun 8, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico IV, L.P. | 2.30M | 2.9% | SCHEDULE 13G/A ↗ |
| Jun 8, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico Advisors IV, Ltd. | 2.30M | 2.9% | SCHEDULE 13G/A ↗ |
| Apr 27, 2026 | SCHEDULE 13G | HNGE Hinge Health, Inc. | HANSAINVEST Hanseatische Investment-Limited Co | 1.48M | 2.7% | SCHEDULE 13G ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Mar 9, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico IV (Guernsey), L.P. | 4.14M | 5.1% | SCHEDULE 13G/A ↗ |
| Mar 9, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico IV, L.P. | 4.14M | 5.1% | SCHEDULE 13G/A ↗ |
| Mar 9, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Atomico Advisors IV, Ltd. | 4.14M | 5.1% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Deer X & Co. Ltd. | 3.13M | 8.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Deer X & Co. L.P. | 3.13M | 8.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Bessemer Venture Partners X Institutional L.P. | 1.52M | 4.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Bessemer Venture Partners X L.P. | 1.62M | 4.3% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Coatue US 70 LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Coatue Growth Fund IV LP | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Philippe Laffont | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Coatue Management, L.L.C. | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Daniel Antonio Perez | 10.37M | 15.7% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Qian Zhuang | 3.70M | 9.8% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital Ivy Partners, LLC | 1.00M | 2.6% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital IVY, LLC | 829,020 | 2.2% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital HH, LLC | 171,550 | 0.5% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital I Partners, LLC | 2.70M | 7.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | 11.2 Capital I, L.P. | 2.70M | 7.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Panayotis D. Sparaggis | 791,104 | 2.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Alkeon Capital Management LLC | 791,104 | 2.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Holdings Group, LLC | 9.38M | 19.8% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Associates X, Ltd. | 9.38M | 19.8% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Associates X, L.P. | 9.38M | 19.8% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners X (Co-Investors), LP | 111,398 | 0.2% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners (Delaware) X, LP | 742,658 | 1.6% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners (Cayman) X, LP | 3.84M | 8.1% | SCHEDULE 13G/A ↗ |
| Feb 13, 2026 | SCHEDULE 13G/A (amended) | HNGE Hinge Health, Inc. | Insight Venture Partners X, LP | 4.68M | 9.9% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 8:14 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances